GINGER CONN: Open Payments
NPI 1730667759 · MONTICELLO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 21 payments from 9 companies in 2025. Trend: 2023 $385 · 2024 $537 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 6 | $144 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| ABBVIE INC. | 3 | $48 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
| Braeburn Inc. | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: SUBLOCADE, FANAPT, REXULTI, QULIPTA, Auvelity, FREESTYLE LIBRE 3, ABILIFY MAINTENA, MOUNJARO.
Industry payments across KY — which companies pay providers there.
